Background: The popularity of implant-based breast reconstruction, along with the well-established benefits of radiation therapy, unfortunately can lead to device placement into irradiated fields. Here, we compare prosthetic reconstructions with latissimus dorsi (LD) or subpectoral implants alone via systematic meta-analysis. Methods: A literature search identified articles involving prosthetic-based breast reconstruction in the setting of prior irradiation with or without an LD flap. The primary outcomes of interest, including device loss, capsular contracture, reoperation, and infection, were analyzed via head-to-head meta-analysis. Results: Thirty-one studies and 1275 reconstructions were included. Average age was 48.9 years and average follow-up was 42.8 months. The head-to-head odds ratio for implant loss with implant-only versus LD-assisted reconstruction was 4.33 (P = 0.0003, I 2 = 7%), favoring LD-assisted reconstruction. Implant loss in pooled analysis was 5.0% for LD-assisted reconstruction and 15.0% for implant-only (P G 0.001). Conclusions: In previously irradiated fields, prostheses placed with an LD f lap demonstrated a clinically significant reduction in device loss, infection, and reoperation. was responsible for the study design, conception, drafting, and critical revisions; M.N.B., data collection, data analysis, drafting, and critical revisions; V.S., data collection, data analysis, and critical revisions; and J.M.S. and J.F., critical revisions. Conflicts of interest and sources of funding: none declared. Reprints:
M ore than 1.6 million individuals were diagnosed with cancer in the United States in 2012 alone, including 225,000 women with breast cancer. 1 Radiation continues to be an important pillar in the treatment of breast cancer, both as an established means of locoregional control, 2,3 and through long-term mortality survival benefit. 3 Yet, with the rising use of implant-based breast reconstruction, 4 it is clear that plastic surgeons will be faced with more irradiated fields in need of reconstruction.
Despite the potential oncologic benefits, radiation injures healthy tissue in the targeted field and inadvertently alters surrounding tissues via the bystander effect. 5 Radiation causes damage to DNA and triggers activity of reactive oxygen species, perpetuating cellular injury to eliminate cancer cells, but also irreversibly compromising the local architecture of healthy tissue. Radiation creates a significantly more challenging and complication-prone defect for surgeons to reconstruct, as demonstrated in a recent systematic review by Momoh et al. They demonstrated a high rate of major surgical complications (49%), capsular contractures (25%), and reconstructive failures (19%) in implants placed into irradiated fields. 6 These findings underscore the importance of evidence-based practice measures to guide clinical practice in managing patients seeking implant-based reconstruction after radiation.
In the setting of preoperative radiation in which a prosthetic reconstruction is planned or needed, the surgeon is faced with several critical decisions. Should a separate donor site be created to harvest autologous tissue [latissimus dorsi (LD) f lap] to protect the prosthesis? To date, there is no meta-analysis that addresses the benefit of prophylactically using an LD f lap in reconstructing the irradiated field. We aim to compare outcomes of implant with an LD f lap versus implant-only reconstructions in previously irradiated fields through a systematic meta-analysis of the current literature. Although it is a common practice to cover a prosthetic device with a nonirradiated muscle f lap such as the LD, it is critically important to have evidence-based data to assist with risk counseling and decision making. Such data may provide the foundation for more accurate preoperative risk counseling, improved perioperative decision making, and potentially translate into more cost-efficient care for these reconstructive patients.
METHODS

Literature Search
A literature search was conducted to identify all articles involving prosthetic-based breast reconstruction in the setting of prior irradiation with or without an LD flap. Ovid MEDLINE and EMBASE were searched using the following headings and keyword terms: ''breast reconstruction,'' or ''breast implant,'' or ''breast prosthesis'' or ''latissimus,'' AND ''radiotherapy,'' or ''radiation'' or ''chemoradiotherapy.'' Additionally, selected study references and review articles were examined for further article sources.
Assessment of Methodological Quality
After identifying relevant studies through title and abstract information, studies were selected for inclusion based on the following inclusion criteria: 1) study involved the use of implants in breast reconstruction, with or without an immediate LD f lap and study described surgical protocol; 2) study involved reconstruction in the setting of prereconstruction irradiation, including premastectomy or postmastectomy radiation, but before any breast reconstruction, and study reported outcomes for this group specifically; 3) study was published between 1985 and 2013; 4) study reported relevant outcomes data; 5) study was not limited to single case reports or review of literature; and 6) study was in English.
Studies were excluded if they did not meet the previously mentioned criteria. Additionally, if multiple publications were from the same group, only studies that reported data from nonoverlapping periods were included. The articles were screened to ensure adequate data regarding the primary outcomes: defined as relative risk for device loss, severe capsular contracture (Baker grade III or IV), reoperation rate, and wound infection. If no comparison group was provided, articles were included for secondary outcomes only, defined as point incidence of device loss, capsular contracture, or wound complications. Studies were then rated on methodological quality based on the American Society of Plastic Surgery's Levels of Evidence rating scale for therapeutic studies. 7
Data Extraction
Data were extracted by either of 2 members of the study team (M.N.B. or V.S.). Patient characteristics included age (years), body mass index (kg/m 2 ), average time interval between radiation and subsequent reconstruction, and average or range of radiation dose in grays (Gy) when available. Operative characteristics recorded were reconstructive timing (immediate or delayed), single-or 2-stage implant reconstruction, and whether reconstruction was assisted with an LD f lap. Outcomes of interest included incidence of implant loss, wound infection, reoperation, and severe capsular contracture. Implant loss was defined as removal or exchange of implant, or need for subsequent autologous reconstruction for any reason except undesirable aesthetic outcome. Similarly, reoperation was considered when the indication was a complication, and revisions to improve aesthetics were considered separately from this outcome and recorded when available. Finally, severe capsular contracture was defined as either Baker grade III or IV if reported, or as contracture requiring implant removal due to pain/discomfort. 8 The average length of patient follow-up for each study was noted as well.
Data Analysis
The primary outcomes of interest were analyzed via head-to-head meta-analysis when possible. For those studies that did not include a comparison group, pooled analyses of data were done by reconstructive modality as a secondary outcome. Continuous variables, such as age, were reported via standard summary statistics. Dichotomous data, such as incidence of complications, were summarized with Fisher exact test or W 2 test, significance set to P G 0.05. Meta-analyses of continuous outcomes were reported as weighted mean differences and dichotomous outcomes as odds ratios (ORs) with 95% confidence intervals. A random-effects analytic model was applied, using the method of DerSimonian and Laird, and estimation of heterogeneity derived from the Mantel-Haenszel model. 9 The I 2 statistic, an estimate of heterogeneity, was judged low for I 2 less than 50%, borderline heterogeneous 50% to 75%, and unacceptable greater than 75%. Publication bias was inspected routinely via funnel plots and the Egger et al regression asymmetry test for publication bias. All analyses were conducted in Stata IC 13 
RESULTS
The initial literature search, after removal of duplicate results, yielded 465 unique articles ( Fig. 1 ). Title and abstract search identified 135 articles of potential interest that underwent full manuscript review. A total of 31 studies were included for secondary outcomes and 6 for primary outcomes.
Overall, 31 studies involving 1275 breast reconstructions were included ( Table 1 ). 11Y41 Twenty-two studies were retrospective case series offering level 4 evidence. Nine studies were retrospective or prospective cohorts or case-control studies providing level 3 evidence. Twenty-three studies involved implant-only reconstructions and 15 involved LD-assisted reconstructions. The average age of the sample was 48.9 years, and of the 5 studies reporting body mass index, the average was 25.1 kg/m 2 ( Table 2 ). About half of the studies reported radiation dose or time interval between radiation therapy and reconstruction. The average time to reconstruction was 36.8 months, radiation dose ranged from 45 to 60 Gy, and average follow-up was 42.8 months.
A total of 6 studies compared implant loss rates for LDassisted implant reconstruction versus implant-only reconstruction (Fig. 2 , Table 3 ). The head-to-head OR for implant loss with implant only reconstruction versus LD-assisted reconstruction was 4.33 (P= 0.0003, I 2 = 7%), strongly favoring LD-assisted implant reconstruction. Pooled subgroup analyses were performed for implant loss by reconstructive modality ( Table 4 ). The LD-assisted reconstruction resulted in the lowest incidence of implant loss (5.0%), which was statistically favored when compared to the incidence of implant loss with submuscular only reconstruction (15.0%, P G 0.001).
Head-to-head comparison of LD-assisted versus implant alone demonstrated a greater odds of infection with implant only (OR, 3.04; P = 0.04; I 2 = 0%) and a greater odds of reoperation with implant only (OR, 2.66; P = 0.003; I 2 = 0%) ( Fig. 3 ). There was no statistically significant difference in the rate of Baker grade 3 or 4 capsular contractures comparing LD-assisted and implant-only reconstructions (OR, 1.21; P = 0.74; I 2 = 0%).
Subgroup pooled incidences of complications by reconstructive modality demonstrated statistically lower rates of wound infection with LD-assisted reconstruction (4.0%) versus implant-only reconstruction (6.0%, P = 0.007). Reoperation rate was significantly lower for LD-assisted reconstruction versus implant-only reconstruction (15.0% vs 33.0%, P G 0.001) ( Table 5 ).
DISCUSSION
Radiation, an established therapeutic modality for the treatment of breast cancer, significantly alters the reconstructive surgeon's ability to provide reliable soft tissue coverage over prosthetic devices after mastectomy. Direct molecular and tissue architecture changes ensue in both the targeted and neighboring tissues. Emerging data of Momoh et al 6 have demonstrated the significant challenges and morbidity associated with submuscular implant reconstruction after radiation. The increased utilization of implants, along with technological advances in device engineering, have helped solidify implant reconstruction as the modality of choice for most women; moreover, with the established oncologic benefits of radiation, practicing reconstructive surgeons should expect an increase in encounters requiring device placement into a previously irradiated field. Despite several small series reporting the overall potential benefits in using LD flaps in previously reconstructed fields, there are conflicting reports; in short, there is significant need for better delineation of the risk-benefit of LD assisted. Meta-analysis of the use of LD in previously irradiated breast reconstruction patients will provide a more definitive data which can be communicated to patients and used in preoperative planning. This study represents the first head-to-head meta-analysis of outcomes of implant reconstruction in previously irradiated fields with or without an LD f lap. The data presented here can inform surgeons selecting a technique to reconstruct the previously irradiated chest with a prosthetic device. Furthermore, these findings allow providers to augment the patient's understanding of the riskbenefit of f lap harvest, and may increase the practice of more costefficient medicine.
The incidence of implant loss for LD-assisted reconstruction was 5.0% compared to 15.0% for implant only (P G 0.001). These data underscore the protective effect of providing nonirradiated muscular coverage of devices. Head-to-head analysis of implants with or without an LD flap confirmed this and demonstrated a strongly protective effect conferred by the LD flap with an OR for implant-only reconstructive loss of 4.33 (P = 0.0003, I 2 = 7%). The lower rate of device loss may be attributed to the observed findings that LD flaps were also associated with a significantly lower incidence of infection in pooled analysis (4% vs 6%, P = 0.007). These reduced complication rates with LD likely translated into the observed lower incidence of reoperation in both pooled analysis (15% vs 33%, P G 0.001) and headto-head meta-analysis (OR, 2.66; P = 0.003; I 2 = 0%). The incidence of contracture was not significantly different in head-to-head analysis, but trended toward significance in favor of LD in the pooled analysis (8% vs 16%, P = 0.06).
In summary, our findings demonstrate that complication rates for prostheses placed into irradiated fields are lower when an LD is used with respect to device loss, infection, and reoperation. There is a clinically significant trend toward reduced capsular contracture with LD but this did not achieve statistical significance. The benefit of using the LD, a nonradiated flap, may decrease wound and device complications by providing a stable vascularized construct more resistant to infection and capsular formation. Minimizing direct contact between the prosthesis and the overlying irradiated tissue using an autologous flap may ultimately increase the rate of successful reconstructions. 42 There are several important limitations to this study which merit discussion. First, there was the potential for a significant degree of heterogeneity in patient populations, studies, and reconstructions. For this reason, careful inclusion criteria and analytic techniques were used to both critically assess and account for heterogeneity across and within studies. The average follow-up was 42.8 months, which certainly will not capture all long-term device-related complications and is another criticism. These observations underscore the importance of continued data reporting on implant outcomes to synthesize larger single and multi-institutional experiences. One of the greater limitations of this study is that we were unable to compare the performance of tissue expanders versus permanent implants in irradiated fields, as well as outcomes with immediate versus delayed breast reconstruction. This current study does not address whether to do a latissimus before or after radiation, but does provide data that suggest performing a latissimus with an implant into an irradiated field is superior than an implant alone. Additionally, specific details on device type, fill volumes, and the type of LD harvested (sparing vs total) may play a role in outcomes for which we were unable to account.
Another limitation and simultaneously important observation is the inconsistent and unstandardized reporting of outcomes. This became most apparent when assessing reoperation rate. We were unable to differentiate between short-and long-term reoperation rates because few studies reported this outcome, and those that did report timing of reoperation used different criteria for short-and long-term reoperations. Similarly, most studies reported reoperation rate due to complications, but elective revision rate was seldom reported in studies involved. These findings necessitate a call-to-action to better improve the standardized reporting of outcomes in prosthesis-based breast reconstruction. Furthermore, relative cost and quality of life measures, which we did not analyze, provide useful information in better appreciating the complete risk-benefit profile of each technique for prosthesis-based reconstruction in irradiated fields.
In this systematic meta-analysis of prosthetic-based reconstruction in previously irradiated fields using either an LD f lap or subpectoral device alone, the authors demonstrate a favorable risk profile for utilization of an LD f lap prophylactically. Latissimus dorsi use was associated with statistically lower incidences of device loss, infection, and reoperation. Although the benefit of an LD f lap is known to many surgeons, this article may help in the counseling 
